• To evaluate the safety and efficacy of a chimeric monoclonal antibody to tumor necrosis factor alpha (TNF alpha) in the treatment of patients with rheumatoid arthritis (RA). (nih.gov)
  • 1 Further, patients with MetS often demonstrate increased systemic levels of proinflammatory mediators, such as interleukin-1 (IL-1), interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-), and C-reactive protein (CRP). (cdeworld.com)
  • Infliximab, an antibody to human tumor necrosis factor alpha, has proved successful in the treatment of severe refractory disease and generally causes only mild side effects. (aafp.org)
  • Radiotherapy Dose in Patients Receiving Immunotherapy. (dana-farber.org)
  • AGS-003 is an autologous immunotherapy prepared from fully matured and optimized monocyte-derived dendritic cells, which are co-electroporated with amplified tumor RNA plus synthetic CD40L RNA. (biomedcentral.com)
  • Renal cell carcinoma (RCC) is an immunologically responsive tumor and until recently, the mainstay for systemic therapy for advanced metastatic RCC was cytokine-based immunotherapy with interleukin 2 (IL-2) and interferon alpha (IFN-α). (biomedcentral.com)
  • So far, the most successful passive immunotherapy directed to VEGF is Bevacizumab, a monoclonal antibody that neutralizes the binding of VEGF to its receptors [5], which has been approved, in combination with chemotherapy, for the treatment of different tumors [6-12]. (researchsquare.com)
  • Active specific immunotherapy is attempted by the immunization of a tumor-bearing patient with autochthonous altered (radiation, chemical) tumor cells. (womenshealthsection.com)
  • Although the pathogenesis of HIV infection and the general virologic and immunologic principles underlying the use of antiretroviral therapy are similar for all HIV-infected persons, unique therapeutic and management considerations apply to HIV-infected children. (cdc.gov)
  • In this study, we compared immune responses to the BNT162b2 mRNA Coronavirus Disease 2019 vaccine in patients with solid tumors ( n = 53) who were on active cytotoxic anti-cancer therapy to a control cohort of participants without cancer ( n = 50). (nature.com)
  • Why and how it is replacing past approaches in the management of solid tumors is the subject of this two-part overview. (cancernetwork.com)
  • The situation with solid tumors is considerably more complex, and the evolution of targeted therapies for these cancers is still in its infancy. (cancernetwork.com)
  • At present, and for some years to come, the treatment of most solid tumors will continue to rely on a patchwork of empirically derived and newly introduced molecularly targeted agents. (cancernetwork.com)
  • However, 36% of immunocompromised patients with IBD and 67% of those on anti-tumor necrosis factor (TNF) inhibitors fell below this threshold. (medscape.com)
  • This antigen sequence represents the complete Bevacizumab binding site and using RFASE as adjuvant, the vaccine (hVEGF 26-104 /RFASE) induces an immune response with VEGF neutralizing activity and anti-tumor effect [15]. (researchsquare.com)
  • Glioblastoma multiforme (also known as WHO II grade IV glioma) is the most common and most severe form of primary malignant brain tumor ( 1 - 3 ). (aacrjournals.org)
  • The commonest malignant tumors of bone are Meta-analysis of 14 randomized trials revealed a signifiplasma cell tumors (Chap. Side impact: dryness of mouth, pores and skin, blurred vision, loss of lodging constipation, bradycardia followed by tachycardia, difficulty with micturation, flushing [url=https://samoore.com/products/buy-finpecia-online/] hair loss jak inhibitor purchase finpecia 1 mg[/url]. (ehd.org)
  • Interferon secreted by leukocytes , fibroblasts , or lymphoblasts in response to viruses or interferon inducers other than mitogens, antigens , or allo-antigens. (lookformedical.com)
  • There are still significant barriers to therapeutic success because of tumor-specific antigens (TA) and toxicities associated with treatment [ 19 ]. (biomedcentral.com)
  • We have surveyed the international literature from the meta-analysis (2006) to summarize and assimilate current biological evidence that indicates a potent impact of this molecule upon the tumor microenvironment and STAT signaling, as well as the immunological polarization of the tumor tissue in vivo. (biomedcentral.com)
  • Dysregulation of various cells in the tumor microenvironment (TME) causes immunosuppressive functions and aggressive tumor growth. (biomedcentral.com)
  • The pineal gland, the gland that translates darkness into an endocrine signal by releasing melatonin at night, is now considered a key player in the mounting of an innate immune response. (frontiersin.org)
  • At 1 week after a third immunization, 16 participants demonstrated a median threefold increase in neutralizing antibody responses, but no improvement was observed in T cell responses. (nature.com)
  • Notably, organ transplant recipients mount very poor antibody responses to the first mRNA immunization relative to healthy individuals 10 , which increase somewhat after the second immunization 8 . (nature.com)
  • Similarly, in patients with cancer with solid or hematological malignancies, antibody responses are markedly diminished after the first immunization but improve somewhat after the second 9 . (nature.com)
  • Most intraperitoneal radionuclide therapies of ovarian cancer have used β-emitter antibody conjugates (radioimmunotherapy) and have resulted in dose-limiting marrow suppression ( 1 - 10 ). (snmjournals.org)
  • Polyclonal antibody response was specific to VEGF, and showed no cross reactivity with other VEGF family members like VEGF-C and VEGF-D. Specific IgM, IgA and IgG antibodies detected in the serum of vaccinated patients were able to block the binding of VEGF to its receptors VEGFR1 and VEGFR2. (researchsquare.com)
  • These elicited antibodies impaired the high affinity interaction between VEGF and monoclonal antibody Bevacizumab, an antiangiogenic drug approved in combination with chemotherapy for the treatment of different tumors. (researchsquare.com)
  • CIGB-247 was immunogenic in a broader patient population, and induced Bevacizumab-like polyclonal antibodies, indicating that the VEGF-specific antibody response could have a potentially relevant clinical activity. (researchsquare.com)
  • Elicited polyclonal antibody response in addition to its cross-reactivity with human VEGF, have also demonstrated in rats and monkeys its capacity to impair the binding of Bevacizumab to VEGF [15, 16], indicating the presence of antibodies that block binding sites on VEGF which have shown to be clinically relevant. (researchsquare.com)
  • Investigation therapeutic relationship between stimulant treatment. (myjuicecup.com)
  • The spread of tumor in the peritoneal cavity is an adverse factor and therapeutic challenge for a variety of malignancies. (snmjournals.org)
  • The dose as a component of Zevalin ® (ibritumomab tiuxetan) Therapeutic Regimen is 250 mg/m 2 ( 2.4 ). (drugs.com)
  • Many of these are driven by the same immunologic mechanisms responsible for the drugs' therapeutic effects, namely blockade of inhibitory mechanisms that suppress the immune system and protect body tissues from an unconstrained acute or chronic immune response. (bmj.com)
  • However, cancer cells exploit these checkpoints to evade immune surveillance and suppress antitumor immune responses. (biomedcentral.com)
  • Tumor lysis syndrome: Administer aggressive intravenous hydration, anti-hyperuricemic agents, monitor renal function ( 5.5 ). (drugs.com)
  • Armed with new information about the immune response to allografting, researchers revived interest in renal transplantation. (medscape.com)
  • Here, in Part I, we describe areas where major inroads were initially achieved by targeting angiogenesis (central to the biology of renal cell carcinoma and hepatocellular cancer) and by unraveling pathways in the heterogeneous tumors of mesenchymal origin-spurred by the identification of c-Kit-activating mutations in gastrointestinal stromal tumors (GIST) and the regressions that ensued when tumors harboring these mutations were exposed to the tyrosine kinase inhibitor imatinib (Gleevec). (cancernetwork.com)
  • For this reason, the skin is often exposed to potentially hazardous agents, including chemicals, which may contribute to the onset of a spectrum of adverse health effects ranging from localized damage (e.g., irritant contact dermatitis and corrosion) to induction of immune-mediated responses (e.g., allergic contact dermatitis and pulmonary responses), or systemic toxicity (e.g., neurotoxicity and hepatoxicity). (cdc.gov)
  • The points in the figures showing no-observed-adverse-effect levels (NOAELs) or lowest observed-adverse-effect levels (LOAELs) reflect the actual doses (levels of exposure) used in the studies. (cdc.gov)
  • Proportion of patients with serious adverse events with a causal relationship (definite, very probable or probable) with the immunomodulator VSSPs. (who.int)
  • Basal cell carcinoma (BCC) is a nonmelanocytic skin cancer (ie, an epithelial tumor) that arises from basal cells (ie, small, round cells found in the lower layer of the epidermis). (medscape.com)
  • Because prostate cancer has generally a low proliferation index, such as tapeworms or hookworms, are en- doparasites that live inside their host. (banglaforexacademy.com)
  • In making the overall evaluation, the Working Group considered the following evidence: (i) Although Perc is known to induce peroxisome proliferation in mouse liver, a poor quantitative correlation was seen between peroxisome proliferation and tumor formation in the liver after administration of Perc by inhalation. (who.int)
  • Angiogenesis is the formation of new blood vessels from the existing vasculature, and it is significantly increased during tumor development with the aim to supply nutrients and oxygen that support the high rate proliferation of tumor cells. (researchsquare.com)
  • other studies have suggested additional roles for immunologic factors in mediating this molecularly heterogeneous and often rapidly fatal neoplasm ( 5 - 8 ). (aacrjournals.org)
  • We describe areas where major inroads were initially achieved by targeting angiogenesis and by unraveling pathways in the heterogeneous tumors of mesenchymal origin-spurred by the identification of c-Kit-activating mutations in GIST and the regressions that ensued when tumors harboring these mutations were exposed to the tyrosine kinase inhibitor imatinib (Gleevec). (cancernetwork.com)
  • Bacteremias in the systemic circulation and bacterial byproducts (eg, endotoxins), as well as the resultant proinflammatory cytokines produced in response to those bacteria, may result in a systemic immune response, dyslipidemia, and an increased risk of atherosclerotic lesion formation. (cdeworld.com)
  • VEGF biological activity is mediated by its binding to VEGFR receptor 2 (VEGFR2) or VEGF receptor 1 (VEGFR1) [2], and both interactions have been implicated in tumor-induced angiogenesis and immunosuppression [3, 4]. (researchsquare.com)
  • Efforts should also be made to gauge the effects of such factors as immunologic surveillance and chemical cocarcinogens on ultraviolet photocarcinogenesis. (cdc.gov)
  • Association of Pretreatment Circulating Tumor Tissue-Modified Viral HPV DNA With Clinicopathologic Factors in HPV-Positive Oropharyngeal Cancer. (dana-farber.org)
  • Arguably the two most prominent factors are genetic variability and immunologic status of the exposed individual. (hindawi.com)
  • Initiation of therapy in the asymptomatic person is more complex and involves consideration of multiple virologic, immunologic, and psychosocial factors. (cdc.gov)
  • A protein-serine-threonine kinase that is activated by PHOSPHORYLATION in response to GROWTH FACTORS or INSULIN. (lookformedical.com)
  • Postoperative radiation can also be a useful adjunct when patients have aggressive tumors that were treated surgically or when surgery has failed to clear the margins of the tumor. (medscape.com)
  • A specific immune response elicited by a specific dose of an immunologically active substance or cell in an organism, tissue, or cell. (nih.gov)
  • These results suggest that a third dose of BNT162b2 is safe, improves humoral immunity against SARS-CoV-2 and could be immunologically beneficial for patients with cancer on active chemotherapy. (nature.com)
  • More commonly, multidrug regimens incorporating drugs with different mechanisms of action and different toxicities are used to increase efficacy, reduce dose-related toxicity, and decrease the probability of drug resistance. (msdmanuals.com)
  • The lack of substantial toxicity was consistent with the dosimetry assessments (mean equivalent dose to marrow, 0.18 mSv/MBq). (snmjournals.org)
  • Five dose levels of intraperitoneal 212 Pb-TCMC-trastuzumab treatment of patients with peritoneal carcinomatosis showed little agent-related toxicity, consistent with the dosimetry calculations. (snmjournals.org)
  • Among other α emitters in clinical trials, dose escalations have been well tolerated, without dose-limiting toxicity ( 13 ). (snmjournals.org)
  • It's estimated that [approximately 4%] of patients can't take the COVID vaccines or booster shot because they have some type of intolerance or allergy or an immunologic nonresponse . (medscape.com)
  • The spectrum of mutations in proto-oncogenes in liver tumors from mice treated with Perc was different from that in liver tumors from mice treated with trichloroethylene (TCE). (who.int)
  • Neutralizing antibodies were detected in 67% of patients with cancer after the first immunization, followed by a threefold increase in median titers after the second dose. (nature.com)
  • Similar patterns were observed for spike protein-specific serum antibodies and T cells, but the magnitude of each of these responses was diminished relative to the control cohort. (nature.com)
  • For example, patients with autoimmune conditions or chronic lymphocytic leukemia treated with B cell-depleting antibodies have predictably diminished humoral responses to vaccination, whereas responses by patients on anti-TNF therapies are less affected 6 , 7 . (nature.com)
  • Three months after the second dose of the vaccine, only 8% of healthy volunteers fell below the proposed protective threshold of neutralizing antibodies for the Delta variant. (medscape.com)
  • It has been more than 10 years since the pivotal trial E1684 first showed improvement in overall survival (OS) for melanoma patients treated with adjuvant high-dose interferon (HDI) [ 1 ], but controversies continue regarding the use of interferon (IFN) as adjuvant therapy in melanoma patients. (biomedcentral.com)
  • The dose for RA in combination with methotrexate is two-1,000 mg intravenous infusions separated by 2 weeks (one course) every 24 weeks or based on clinical evaluation, but not sooner than every 16 weeks. (drugs.com)
  • The follow up dose for adult patients with GPA and MPA who have achieved disease control with induction treatment, in combination with glucocorticoids is two 500 mg intravenous infusions separated by two weeks, followed by a 500 mg intravenous infusion every 6 months thereafter based on clinical evaluation ( 2.6 ). (drugs.com)
  • This report shows the characterization of the humoral response elicited after vaccination with 400 µg of antigen combined with 200 µg of VSSP in cancer patients representative of the Cuban real clinical practice setting. (researchsquare.com)
  • Infant pain scales is probably not as clinically helpful because the responses could also be dampened or is probably not identifed by caregivers. (ehd.org)
  • This document provides the scientific rationale and framework for the assignment of multiple hazard-specific skin notations (SK) that clearly distinguish between the systemic effects, direct (localized) effects, and immune-mediated responses caused by skin contact with chemicals. (cdc.gov)
  • Proteins secreted by vertebrate cells in response to a wide variety of inducers. (lookformedical.com)
  • In contrast, other drugs (eg, DNA cross-linkers, also known as alkylating agents) have a linear dose-response relationship, killing more cancer cells at higher doses. (msdmanuals.com)
  • In patients who had sequential samples available for immune monitoring, the magnitude of the increase in the absolute number of CD8 + CD28 + CD45RA − effector/memory T cells (CTLs) after 5 doses of AGS-003 relative to baseline, correlated with overall survival. (biomedcentral.com)
  • Here we report, using the pathogenic model of antiretroviral therapy-treated, SIV-infected rhesus macaques that sequential interleukin-21 and interferon alpha therapy generate terminally differentiated blood natural killer cells (NKG2a/c low CD16 + ) with potent human leukocyte antigen-E-restricted activity in response to SIV envelope peptides. (nature.com)
  • The frequency of treatment will initially be once a week for 3 weeks and then biweekly or monthly until 24 months, depending on the response of myeloid suppressor cells (MDSC) on days 21 and 28. (who.int)
  • This innovative approach enhances the patient's immune system to target and eliminate tumor cells. (biomedcentral.com)
  • As has often been the case, hematologic malignancies have led the way in the introduction of this new generation of therapeutics-perhaps because of easy access to tumor samples for pharmacodynamics, and the narrow spectrum of cells of origin. (cancernetwork.com)
  • A cell line derived from cultured tumor cells. (lookformedical.com)
  • Previously untreated follicular, CD20-positive, B-cell NHL in combination with first line chemotherapy and, in patients achieving a complete or partial response to a rituximab product in combination with chemotherapy, as single-agent maintenance therapy. (drugs.com)
  • A systematic study using Sk-1-hairless-mice was made of the dependence of squamous cell cancer development on ultraviolet (UV) wavelength distribution, total dose, and dose fractionation in a manner simulating solar radiation at various stages of ozone depletion. (cdc.gov)
  • He is actively evaluating the immunologic effects of radiation therapy and exploring treatments combining radiation with novel immune oncology agents. (dana-farber.org)
  • Association between radiation dose to organs at risk and acute patient reported outcome during radiation treatment for head and neck cancers. (dana-farber.org)
  • There isn't any difference in native control or survival between high dose rate brachytherapy in contrast with exterior beam radiation [url=https://samoore.com/products/purchase-cytotec-no-rx/] symptoms 8dpiui cytotec 200 mcg online[/url]. (ehd.org)
  • Speculation about genetic, environmental, dietary, infectious, and immunologic etiologies has led to treatment modalities directed at each theoretic cause, but therapy guidelines are determined by the severity of disease. (aafp.org)
  • 2 The etiology of Crohn's disease is unknown, but suggested possibilities include genetic, environmental, immunologic, and infectious causes. (aafp.org)
  • AGS-003 in combination with sunitinib was well tolerated and yielded supportive immunologic responses coupled with extension of median and long-term survival in an unselected, intermediate and poor risk prognosis mRCC population. (biomedcentral.com)
  • IRF proteins bind specific DNA sequences such as interferon-stimulated response elements, interferon regulatory elements, and the interferon consensus sequence. (lookformedical.com)
  • attempts to demonstrate virus-specific sequences in human tumors. (liverpool.ac.uk)
  • Together, these data provide a mechanistic basis for considering pinealocytes a target of TNF and reinforce the idea that the suppression of pineal melatonin is one of the mechanisms involved in mounting an innate immune response. (frontiersin.org)
  • Besides, the TME employs several mechanisms to suppress immune responses. (biomedcentral.com)
  • Stat1 interacts with P53 TUMOR SUPPRESSOR PROTEIN and regulates expression of GENES involved in growth control and APOPTOSIS . (lookformedical.com)
  • Furthermore, modulation of this S1→ACC projection regulates aversive responses to pain. (iasp-pain.org)
  • Frequent dosing for extended periods may necessitate intravenous implanted access devices. (msdmanuals.com)
  • The induction dose for adult patients with active GPA and MPA in combination with glucocorticoids is 375 mg/m 2 once weekly for 4 weeks. (drugs.com)
  • Although SEGAs did not resolve completely, new tumors did not occur during treatment. (medscape.com)
  • We may also take a look at how fertility therapies are supporting new family relationships and helping those with critical inherited genetic problems to have youngsters [url=https://samoore.com/products/purchase-online-tinidazole/] antibiotic 272 safe tinidazole 1000mg[/url]. (ehd.org)
  • SEGAs are slow-growing, benign brain tumors that occur in up to 20% of patients with tuberous sclerosis , a genetic disorder that affects about 25,000 to 40,000 people in the United States. (medscape.com)
  • The primary endpoint was to determine the complete response rate. (biomedcentral.com)
  • Of 4 patients whose tumors returned after surgery, 3 met the endpoint of a 50% or greater reduction in tumor volume. (medscape.com)
  • Mild temperature rise might be transient in nature and can emerge from the body's response to tissue harm [url=https://samoore.com/products/buy-online-sominex-cheap/] insomnia book order 25mg sominex with visa[/url]. (ehd.org)
  • More worrisome was the observation that, when assessing these patients out to 6 months beyond the second dose, only 17% of the healthy patients dropped below the estimated protection threshold, compared with 58% of the immunocompromised patients and 100% of those on TNF inhibitors. (medscape.com)
  • In contrast to the VEGF and mTOR inhibitors, durable and complete responses have been observed with high dose (HD) IL-2, indicating the importance of immune modulation in this disease process [ 5 ]. (biomedcentral.com)
  • Unlike HIV infection, which progresses to AIDS absent suppressive anti-retroviral therapy, nonpathogenic infections in natural hosts, such African green monkeys, are characterized by a lack of gut microbial translocation and robust secondary lymphoid natural killer cell responses resulting in an absence of chronic inflammation and limited SIV dissemination in lymph node B-cell follicles. (nature.com)
  • For each cancer discussed in the first part of our overview, as well as in Part II, which will deal with more common cancers, we briefly cover the tumor biology, how targeting was achieved, the introduction of immune modulation or immune-conjugates, and the impact these therapies are having in the disease. (cancernetwork.com)
  • In most patients with cancer, we detected spike receptor-binding domain and other S1-specific memory B cell subsets as potential predictors of anamnestic responses to additional immunizations. (nature.com)
  • Dose modification or exclusion of certain drugs may be necessary in patients with lung disease (eg, bleomycin), kidney failure (eg, methotrexate), liver dysfunction (eg, taxanes) or heart disease (daunorubicin, cyclophosphamide). (msdmanuals.com)
  • In a standard 3 + 3 phase 1 design for dose escalation, 212 Pb-TCMC-trastuzumab was delivered intraperitoneally less than 4 h after administration of trastuzumab (4 mg/kg intravenously) to patients with peritoneal carcinomatosis who had failed standard therapies. (snmjournals.org)
  • Rheumatoid Arthritis (RA) in combination with methotrexate in adult patients with moderately-to severely-active RA who have inadequate response to one or more TNF antagonist therapies ( 1.3 ). (drugs.com)
  • After completion of the first cycle of sunitinib, patients were treated with AGS-003 every 3 weeks for 5 doses, then every 12 weeks until progression or end of study. (biomedcentral.com)
  • however there were no complete responses in this group of intermediate and poor risk mRCC patients and enrollment was terminated early. (biomedcentral.com)
  • Seven (33%) patients survived for at least 4.5 years, while five (24%) survived for more than 5 years, including 2 patients who remain progression-free with durable responses for more than 5 years at the time of this report. (biomedcentral.com)
  • While 25% may show response, only 5-8% of patients experience durable complete responses. (biomedcentral.com)
  • Premedicate patients with an antihistamine and acetaminophen prior to dosing. (rituxan-hcp.com)
  • 32%) of patients achieved more than 50% shrinkage of their largest SEGA tumor at 6 months. (medscape.com)
  • Marketed as Zortress (Novartis), it is also indicated for use with low-dose cyclosporine , basiliximab , and corticosteroids to prevent organ rejection in adult kidney transplant patients at low to moderate immunologic risk. (medscape.com)
  • Our evaluation indicates that although the Sharap service enables the affluent to choose their preferred physician, resulting in a different doctor-patient relationship, the service does not create a significant feeling of discrimination among hospitalized patients, and does not interfere with the high level of health services available to the public at large. (ima.org.il)
  • A provocative study led by investigators at Washington University in St. Louis looked at the protection against COVID variants, including Delta, after the second dose of the vaccine. (medscape.com)
  • It has necrotizing activity against tumor cell lines and increases ability to reject tumor transplants. (lookformedical.com)
  • Antimetabolites such as fluorouracil and methotrexate are cell cycle-specific and have a nonlinear dose-response relationship. (msdmanuals.com)
  • This mode of cell death serves as a balance to mitosis in regulating the size of animal tissues and in mediating pathologic processes associated with tumor growth. (lookformedical.com)
  • Overall duration of response ranged from about 3 months to 2.5 years (median, 266 days). (medscape.com)
  • Cite this: FDA Approves First Therapy for Tuberous Sclerosis Tumors - Medscape - Nov 02, 2010. (medscape.com)
  • Chronic pain enhances this cortico-cortical connection, as manifested by an increased number of ACC neurons that respond to S1 inputs and the magnified contribution of these neurons to the nociceptive response in the ACC. (iasp-pain.org)
  • Animals with pain after chronic constriction injury of the infraorbital nerve (CCI-Pain) displayed higher spontaneous and evoked activity in PB neurons, and a dramatic increase in after-discharges-responses that far outlast the stimulus-compared to controls. (iasp-pain.org)
  • At high doses, DNA cross-linkers damage the bone marrow. (msdmanuals.com)
  • one-hit response relationship between the number of colonies and the virus dose was observed with high dilutions of the virus preparation. (liverpool.ac.uk)
  • LOAELs or NOAELs should also help in determining whether or not the effects vary with dose and/or duration, and place into perspective the possible significance of these effects to human health. (cdc.gov)
  • primary outcomes were immune responses, with a secondary outcome of safety. (nature.com)
  • The authors studied the effects of mild hypothermia on the outcome in a rat model of intraabdominal sepsis and tested whether granulocyte colony-stimulating factor (G-CSF) augments the host response and improves outcome during mild hypothermia. (asahq.org)
  • Therefore, melatonin is now considered to play an important role in the modulation of inflammatory responses. (frontiersin.org)
  • We examined the relationships of human leukocyte antigen (HLA) and related polymorphisms to glioblastoma multiforme in adult Caucasians (non-Hispanic Whites) from the San Francisco Bay area. (aacrjournals.org)
  • The onset of reduction in intraocular pressure following administration of Timolol Maleate Ophthalmic Solution can usually be detected within one-half hour after a single dose. (nih.gov)
  • The maximum effect usually occurs in one to two hours and significant lowering of intraocular pressure can be maintained for periods as long as 24 hours with a single dose. (nih.gov)
  • Injection: 100 mg/10 mL (10 mg/mL) and 500 mg/50 mL (10 mg/mL) solution in single-dose vials ( 3 ). (drugs.com)